Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 91 to 105 of 121 results for psychosis

  1. What are the service and service user characteristics of highly specialist and longer-term high-dependency rehabilitation units that are associated with better outcomes?

    Comes from guidance Rehabilitation for adults with complex psychosis Number NG181 Date issued August 2020 Other details

    Research recommendation
    Published
    26 October 2020

  2. Research recommendations

    protective factors, and course of illness for different combinations of psychosis and coexisting substance misuse (for example,...

  3. Content and nature of effective de-escalation:- What is the content and nature of effective de-escalatory actions, interactions and activities used by mental health nurses, including the most effective and efficient means of training nurses to usethem in a timely and appropriate way?

    and test these techniques with adults who have cognitive impairment or psychosis. In addition, research should be carried out to develop...

    Research recommendation
    Published
    5 October 2015

  4. THINK delirium in intensive care

    diagnostic tests. Differential diagnosis: depression, dementia, acute psychosis. Trigger: look for change in behaviour. NICE lists 15...

    Shared learning
    Last updated
    1 July 2021

  5. What is the clinical and cost effectiveness of inpatient rehabilitation provided by the independent sector compared with that provided by the NHS?

    Comes from guidance Rehabilitation for adults with complex psychosis Number NG181 Date issued August 2020 Other details

    Research recommendation
    Published
    26 October 2020

  6. Medicines associated with dependence or withdrawal symptoms. Patient decision aid full version on should I stop my benzodiazepine or z-drug?

    people can even have fits or have strange thoughts and ideas, known as psychosis. Withdrawal effects can feel like the original anxiety...

  7. Attention deficit hyperactivity disorder: diagnosis and management (NG87)

    This guideline covers recognising, diagnosing and managing attention deficit hyperactivity disorder (ADHD) in children, young people and adults. It aims to improve recognition and diagnosis, as well as the quality of care and support for people with ADHD.

    NICE guideline
    Last updated
    13 September 2019
    View recommendations

    Sections for NG87

  8. Borderline personality disorder: recognition and management (CG78)

    This guideline covers recognising and managing borderline personality disorder. It aims to help people with borderline personality disorder to manage feelings of distress, anxiety, worthlessness and anger, and to maintain stable and close relationships with others.

    Clinical guideline
    Published
    28 January 2009
    View recommendations

    Sections for CG78

  9. KardiaMobile 6L for measuring cardiac QT interval in adults having antipsychotic medication (HTE10)

    Early value assessment (EVA) guidance on KardiaMobile 6L for measuring cardiac QT interval in adults having antipsychotic medication....

    Health technology evaluation
    Published
    26 September 2023
    View recommendations

    Sections for HTE10

  10. Violence and aggression: short-term management in mental health, health and community settings (NG10)

    This guideline covers the short-term management of violence and aggression in adults (aged 18 and over), young people (aged 13 to 17) and children (aged 12 and under). It is relevant for mental health, health and community settings. The guideline aims to safeguard both staff and people who use services by helping to prevent violent situations and providing guidance to manage them safely when they occur.

    NICE guideline
    Published
    28 May 2015
    View recommendations

    Sections for NG10

  11. Psychosis and schizophrenia: management (CG82)

    This guidance has been updated and replaced by NICE guideline CG178. This guideline updates and replaces NICE guideline CG1.    

    Clinical guideline
    Published
    25 March 2009

  12. Esketamine nasal spray for treatment-resistant depression (TA854)

    Evidence-based recommendations on esketamine (Spravato) for treatment-resistant depression in adults.

    Technology appraisal guidance
    Published
    14 December 2022
    View recommendations

    Sections for TA854

  13. Social anxiety disorder: recognition, assessment and treatment (CG159)

    This guideline covers recognising, assessing and treating social anxiety disorder (also known as ‘social phobia’) in children and young people (from school age to 17 years) and adults (aged 18 years and older). It aims to improve symptoms, educational, occupational and social functioning, and quality of life in people with social anxiety disorder.

    Clinical guideline
    Published
    22 May 2013
    View recommendations

    Sections for CG159

  14. Transition between inpatient mental health settings and community or care home settings (NG53)

    This guideline covers the period before, during and after a person is admitted to, and discharged from, a mental health hospital. It aims to help people who use mental health services, and their families and carers, to have a better experience of transition by improving the way it’s planned and carried out.

    NICE guideline
    Published
    30 August 2016
    View recommendations

    Sections for NG53

  15. Antisocial behaviour and conduct disorders in children and young people (QS59)

    This quality standard covers recognising and managing antisocial behaviour and conduct disorders in children and young people. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    17 April 2014
    View quality statements

    Sections for QS59